VRAX (Virax Biolabs Group) Tax Rate %: 18.91% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRAX Virax Biolabs Group Ltd VRAX
45 GF Score
Price $2.98
GF Value $3.60
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Virax Biolabs Group Tax Rate %?

Virax Biolabs Group VRAX +1.36% 45 Tax Rate % is 18.91% as of Mar. 2026. GuruFocus rates VRAX with a GF Score™ of 45/100 and a GF Value™ of $3.60 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Virax Biolabs Group's Tax Expense for the six months ended in Mar. 2026 was $-0.63 Mil. Virax Biolabs Group's Pre-Tax Income for the six months ended in Mar. 2026 was $-3.32 Mil. Therefore, Virax Biolabs Group's Tax Rate % for the quarter that ended in Mar. 2026 was 18.91%.

Virax Biolabs Group Tax Rate % Related Terms

Virax Biolabs Group Tax Rate % Historical Data

* Premium members only.

The historical data trend for Virax Biolabs Group's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virax Biolabs Group Tax Rate % Chart

Virax Biolabs Group Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Rate %
Get a 7-Day Free Trial 0.00 0.00 0.00 2.21 15.17

Virax Biolabs Group Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.74 0.00 10.47 18.91
VRAX
45GF Score
Virax Biolabs Group Ltd VRAX
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virax Biolabs Group Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Virax Biolabs Group's Tax Rate % for the fiscal year that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (A: Mar. 2026 )/Pre-Tax Income (A: Mar. 2026 )
=-0.9/-5.932
=15.17 %

Virax Biolabs Group's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=-0.627/-3.316
=18.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 18.91% mean?
Virax Biolabs Group (VRAX) has a Tax Rate % of 18.91% as of Mar. 2026.
Is Virax Biolabs Group's Tax Rate % too high?
Virax Biolabs Group's current Tax Rate % is 18.91%. Overall, Virax Biolabs Group has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Virax Biolabs Group's Tax Rate % compare to ISCO and PKTX?
Virax Biolabs Group's Tax Rate % of 18.91% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Virax Biolabs Group's current Tax Rate % is 18.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virax Biolabs Group stock overvalued right now?
Based on GuruFocus' analysis, Virax Biolabs Group (VRAX) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.60, compared to a current price of $2.98 — trading 17.2% below its estimated fair value. The current Tax Rate % is 18.91%. Virax Biolabs Group's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Virax Biolabs Group (VRAX), the current Tax Rate % is 18.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virax Biolabs Group (VRAX) Overvalued in 2026?

Based on GuruFocus' analysis, Virax Biolabs Group stock appears to be undervalued. The current stock price of $2.98 is trading 17.2% below its estimated GF Value™ of $3.60. GuruFocus considers Virax Biolabs Group to be Modestly Undervalued.

Key valuation signals for VRAX:

  • Tax Rate %: 18.91%
  • GF Value™: $3.60 vs. price of $2.98 (17.2% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the VRAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virax Biolabs Group Business Description

Address Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
45GF Score

Get the complete analysis for VRAX

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.98
Price
$3.60
GF Value